Company Filing History:
Years Active: 2025
Title: Di Wu - Innovator in Pharmaceutical Therapy
Introduction
Di Wu is a notable inventor based in Changchun, China. He has made significant contributions to the pharmaceutical field, particularly in the treatment of soft tissue sarcoma. His innovative approach combines quinoline derivatives with antibody therapies, showcasing his commitment to advancing medical science.
Latest Patents
Di Wu holds a patent for a quinoline derivative and antibody soft tissue sarcoma combination therapy. This invention provides a therapeutically effective method for treating soft tissue sarcoma using a specific quinoline derivative compound I, known chemically as 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropylamine. This patent represents a significant advancement in cancer treatment options.
Career Highlights
Di Wu is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His dedication to research and development has positioned him as a key figure in the industry.
Collaborations
Di Wu collaborates with Huan Wang, contributing to the development of new therapeutic strategies. Their partnership exemplifies the importance of teamwork in the pursuit of medical advancements.
Conclusion
Di Wu's work in developing a quinoline derivative and antibody combination therapy highlights his innovative spirit and dedication to improving cancer treatment. His contributions to the pharmaceutical field are noteworthy and reflect the potential for future advancements in medical therapies.